FDA Panel Approves Unverified Peptide Treatments Amid Debate

WHO:

Fast Company - Health Secretary Robert F. Kennedy Jr. has described himself as a "big fan" of peptides and vowed to overturn FDA restrictions put in place under President Joe Biden.

Fast Company - Brigham Buhler, a wellness clinic owner, stated that allowing U.S. pharmacies to compound peptides would help steer Americans away from unvetted products imported from other countries.

Fast Company - David Pope, chief pharmacy officer of Xifin Pharmacy Solutions, stated, "I voted yes because it’s time to put this decision back in the hands of the patient, the physician and the pharmacist."

Fast Company - Dr. Elizabeth Rebello of the University of Texas MD Anderson Center expressed concern, saying, "I’m concerned we’re responding to a market-induced demand rather than a decision based in solid science."

Fast Company - Rita Jew, a pharmacist and president of the Institute for Safe Medication Practices, described the marketplace as a "Wild West" of unproven, unregulated drugs.

Newsweek - Dr. Pieter Cohen stated there is "absolutely not" enough evidence that these peptides are safe for human use.

Wired Science - Outside experts, including some with vested interests in peptides, recommended the addition of certain amino acids to the FDA's bulk list.

NBC News Health - Joe Rogan and other influencers are associated with the promotion of the “Wolverine stack” peptide treatment.

WHAT:

Fast Company - The panel's vote on the peptides was 8-6, with one abstention, and the panel will vote on three more peptides in the following session.

NBC News - If the FDA follows the advisory committee's recommendation, telehealth companies are expected to ramp up marketing of the chemicals for wellness and cosmetic uses.

Fast Company - The panel's vote on the peptides was 8-6, with one abstention, and the panel will vote on three more peptides in the following session.

Fast Company - The FDA is not required to follow the advisory committee's recommendations, though it usually does.

Fast Company - The FDA panel voted 8-6, with one abstention, in favor of putting the peptides BPC-157, TB-500, and KPV on the FDA's list of substances considered safe for pharmacy compounding.

Fast Company - The panel's vote is not binding but is expected to encourage Health Secretary Robert F. Kennedy Jr. to overturn FDA restrictions put in place under President Joe Biden.

Fast Company - The panel will vote on three more peptides in the following session.

Drudge Report - The peptide boom has prompted states to scramble to protect consumers amid growing concerns about the safety and regulation of these treatments.

NBC News - The FDA advisory committee's vote to loosen restrictions on peptides was narrowly passed with a vote of 8-7.

BBC - The FDA panel's recommendation could impact the sale of peptides that are currently not illegal to buy or own, but are not approved for human use and lack the quality controls of pharmaceutical manufacturing.

NBC News - An FDA advisory committee voted narrowly in favor of loosening restrictions on peptides, with the vote reflecting strong objections from agency career scientists.

NBC News Health - An FDA panel made a controversial recommendation regarding the sale of peptides, which are marketed for benefits such as muscle growth and weight loss.

Wired Science - The FDA panel endorsed the addition of unverified peptide treatments to its bulk list.

WHY:

Fast Company - Brigham Buhler stated, "It’s crucial to allow patients to have safe and effective access to these treatment options."

Fast Company - Brigham Buhler, a wellness clinic owner, stated that allowing U.S. pharmacies to compound peptides would help steer Americans away from unvetted products imported from other countries.

NBC News Health - The recommendation has sparked debate, with not everyone agreeing on the efficacy and safety of these treatments.

HOW:

Fast Company - The panel's discussions included over 18 hours of presentations and public comments from more than two dozen speakers, including doctors, lawyers, and peptide entrepreneurs.

Wired Science - The process involved recommendations from outside experts to the FDA regarding the inclusion of specific peptides.

(UPDATED July 24, 2026 20:20 UTC)

Health Secretary Robert F. Kennedy Jr. has expressed his strong support for peptides and is committed to reversing FDA restrictions established during the Biden administration. In a recent advisory panel vote, the recommendation on peptides was narrowly decided at eight to six, with another vote scheduled for additional peptides in the next session. If the FDA adopts the committee's guidance, telehealth companies are poised to significantly increase their marketing of these substances for wellness and cosmetic purposes.

(UPDATED July 24, 2026 18:22 UTC)

In a recent advisory panel meeting, members voted eight to six, with one abstention, on the use of certain peptides, emphasizing the need to return decision-making power to patients, physicians, and pharmacists, as stated by David Pope of Xifin Pharmacy Solutions. However, Dr. Elizabeth Rebello from the University of Texas MD Anderson Center raised concerns about the potential for market-driven demands overshadowing scientific evidence, while Rita Jew, president of the Institute for Safe Medication Practices, described the current drug marketplace as a "Wild West" of unregulated options. The panel's discussions spanned over 18 hours and included insights from a variety of stakeholders, highlighting the importance of ensuring safe and effective access to treatment options, as noted by Brigham Buhler.

(UPDATED July 24, 2026 17:25 UTC)

A panel has voted eight to six, with one abstention, in favor of adding the peptides BPC-157, TB-500, and KPV to the FDA's list of substances deemed safe for pharmacy compounding, a decision that, while not binding, is expected to influence Health Secretary Robert F. Kennedy Jr. to reconsider FDA restrictions established under President Biden. Brigham Buhler, a wellness clinic owner, emphasized that allowing U.S. pharmacies to compound these peptides could help protect Americans from unregulated products coming from abroad. The panel's decision followed extensive discussions, featuring over 18 hours of presentations and public comments from more than two dozen speakers, including doctors, lawyers, and peptide entrepreneurs, with plans to vote on three additional peptides in the next session.

(UPDATED July 24, 2026 16:24 UTC)

Dr. Pieter Cohen has declared that there is "absolutely not" enough evidence to support the safety of certain peptides for human use. In response to the rising popularity of these treatments, states are now scrambling to implement measures to protect consumers amid increasing concerns about their safety and regulation. The situation highlights the urgent need for clarity and oversight in the burgeoning peptide market.

(UPDATED July 24, 2026 12:22 UTC)

In a significant development, the FDA advisory committee has narrowly approved a vote to loosen restrictions on peptides, with the final tally coming in at eight to seven. This decision could pave the way for changes in how these substances are regulated. The implications of this vote are expected to be closely monitored in the coming weeks.

(UPDATED July 24, 2026 05:52 UTC)

A panel from the FDA has made a recommendation that could significantly affect the sale of peptides, which are currently legal to buy and own but are not approved for human use. These substances also lack the quality controls typically associated with pharmaceutical manufacturing. This development raises important questions about safety and regulation in the market for these compounds.

(UPDATED July 24, 2026 01:26 UTC)

An FDA advisory committee has voted narrowly in favor of loosening restrictions on peptides, despite strong objections from agency career scientists. This decision could pave the way for changes in how these substances are regulated. The vote reflects a significant shift in the ongoing debate over peptide use and safety.

(UPDATED July 24, 2026 00:18 UTC)

An FDA panel has made a controversial recommendation to endorse the addition of unverified peptide treatments to its bulk list, which are often marketed for benefits like muscle growth and weight loss. This decision has sparked debate, particularly as outside experts, some with vested interests in peptides, suggested adding certain amino acids to the list, while influencers like Joe Rogan have promoted the “Wolverine stack” peptide treatment. Not everyone agrees on the efficacy and safety of these treatments, highlighting the ongoing discussions surrounding their use.